Tashima T
Pharmaceutics. 2025; 17(2).
PMID: 40006568
PMC: 11859894.
DOI: 10.3390/pharmaceutics17020201.
Badwal A, Singh S
Mol Biol Rep. 2025; 52(1):259.
PMID: 39982610
DOI: 10.1007/s11033-025-10331-7.
Yazdi Z, Roshannezhad S, Sharif S, Abbaszadegan M
J Transl Med. 2024; 22(1):1173.
PMID: 39741289
PMC: 11686959.
DOI: 10.1186/s12967-024-05908-y.
Kumari K, Gusain S, Joshi R
Planta. 2024; 261(1):2.
PMID: 39579237
DOI: 10.1007/s00425-024-04578-w.
Liu J, Zhu L
Molecules. 2024; 29(21).
PMID: 39519677
PMC: 11547573.
DOI: 10.3390/molecules29215036.
Genome editing in Sub-Saharan Africa: a game-changing strategy for climate change mitigation and sustainable agriculture.
Amoah P, Oumarou Mahamane A, Byiringiro M, Mahula N, Manneh N, Oluwasegun Y
GM Crops Food. 2024; 15(1):279-302.
PMID: 39481911
PMC: 11533803.
DOI: 10.1080/21645698.2024.2411767.
Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects.
Sahel D, Giriprasad G, Jatyan R, Guha S, Korde A, Mittal A
RSC Adv. 2024; 14(44):32411-32435.
PMID: 39403159
PMC: 11472282.
DOI: 10.1039/d4ra04838e.
A specific and ultrasensitive Cas12a/crRNA assay with recombinase polymerase amplification and lateral flow biosensor technology for the rapid detection of .
Cheng Y, Lyu J, Han J, Feng L, Li X, Li P
Microbiol Spectr. 2024; 12(10):e0034524.
PMID: 39254031
PMC: 11448057.
DOI: 10.1128/spectrum.00345-24.
Role of CRISPR-Cas systems and anti-CRISPR proteins in bacterial antibiotic resistance.
Kadkhoda H, Gholizadeh P, Kafil H, Ghotaslou R, Pirzadeh T, Rezaee M
Heliyon. 2024; 10(14):e34692.
PMID: 39149034
PMC: 11325803.
DOI: 10.1016/j.heliyon.2024.e34692.
An efficient -inducible CRISPR interference system for group A genetic analysis and pathogenesis studies.
Bjanes E, Stream A, Janssen A, Gibson P, Bravo A, Dahesh S
mBio. 2024; 15(8):e0084024.
PMID: 38953375
PMC: 11323564.
DOI: 10.1128/mbio.00840-24.
Tailoring in fungi for next generation cellulase production with special reference to CRISPR/CAS system.
Mondal S, Halder S, Mondal K
Syst Microbiol Biomanuf. 2024; 2(1):113-129.
PMID: 38624901
PMC: 8319711.
DOI: 10.1007/s43393-021-00045-9.
CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
Rafiq M, Shabbir M, Raza A, Irshad S, Asghar A, Maan M
BioDrugs. 2024; 38(3):387-404.
PMID: 38605260
DOI: 10.1007/s40259-024-00656-3.
Revolutionizing Agriculture: Harnessing CRISPR/Cas9 for Crop Enhancement.
Chovatiya A, Rajyaguru R, Tomar R, Joshi P
Indian J Microbiol. 2024; 64(1):59-69.
PMID: 38468733
PMC: 10924811.
DOI: 10.1007/s12088-023-01154-w.
Genome Engineering as a Therapeutic Approach in Cancer Therapy: A Comprehensive Review.
Gemayel J, Chebly A, Kourie H, Hanna C, Mheidly K, Mhanna M
Adv Genet (Hoboken). 2024; 5(1):2300201.
PMID: 38465225
PMC: 10919288.
DOI: 10.1002/ggn2.202300201.
Escherichia coli CRISPR arrays from early life fecal samples preferentially target prophages.
Dion M, Shah S, Deng L, Thorsen J, Stokholm J, Krogfelt K
ISME J. 2024; 18(1).
PMID: 38366192
PMC: 10910852.
DOI: 10.1093/ismejo/wrae005.
Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency.
Allemailem K
Int J Nanomedicine. 2024; 19:1125-1143.
PMID: 38344439
PMC: 10859101.
DOI: 10.2147/IJN.S453566.
An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
Evmenov K, Pustogarov N, Panteleev D, Safin A, Alkalaeva E
Int J Mol Sci. 2024; 25(3).
PMID: 38338898
PMC: 10855156.
DOI: 10.3390/ijms25031622.
Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases.
Bigini F, Lee S, Sun Y, Sun Y, Mahajan V
Vision Res. 2023; 213:108317.
PMID: 37722240
PMC: 10685911.
DOI: 10.1016/j.visres.2023.108317.
Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases.
Lu X, Zhang M, Li G, Zhang S, Zhang J, Fu X
Int J Mol Sci. 2023; 24(17).
PMID: 37686009
PMC: 10487642.
DOI: 10.3390/ijms241713202.
VIGE: virus-induced genome editing for improving abiotic and biotic stress traits in plants.
Gentzel I, Ohlson E, Redinbaugh M, Wang G
Stress Biol. 2023; 2(1):2.
PMID: 37676518
PMC: 10441944.
DOI: 10.1007/s44154-021-00026-x.